Tenaya Therapeutics Inc (TNYA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TNYA Annual Balance Sheets →
The table below presents a historical view of Tenaya Therapeutics Inc's balance sheet, supporting analysis of financial position trends.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent78.10
Short-term Investments, Total0.00
Cash & Short-term Investments78.00
Accounts receivable0.37
Other Current Assets4.05
Prepaid Expense And Other Assets Current3.49
Total Current Assets86.01
Equipment/Property/Plant Net27.47
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset8.76
Total Assets93.54
Liabilities
Accounts Payable, Current AC2.90
Accrued Liabilities, Current AC7.51
Other Liabilities, Current8.08
Taxes Payable0.53
Total Current Liabilities19.02
Total Long-term Debt0.00
Other liabilities, Noncurrent5.11
Operating Lease Liability Current3.12
Operating Lease Liability Noncurrent7.00
Total Liabilities24.13
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock737.06
Retained Earnings / Accumulated Deficit-667.67
Other Equity0.00
Common Stockholder's Equity69.41
Total Stockholder's Equity69.41
Liabilities & Stockholder's Equity93.54
4 historic quarters locked

Sign in to unlock the full Tenaya Therapeutics Inc balance sheet history.

About Tenaya Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-335140

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.